Gapping up
In reaction to earnings/guidance:
- AFRM +36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US), EDR +20%, DUOL +16.5%, INDI +13%, HRT +11%, PAYO +8.3%, TOST +7.6%, ACET +7.3%, CORZ +7%, VZIO +5.7%, RYAN +5.6%, HNST +3.4%, MSI +2.7%, AQN +1.9% (also increases dividend), LZ +1.1%, HMC +1.1%, POSH +0.8%
Other news:
- HOOD +22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund)
- COIN +13% (in sympathy with HOOD news)
- DVAX +11.5% (to join S&P SmallCap 600)
- AOSL +10% (to join S&P SmallCap 600)
- DWAC +7.5% (shares higher following Elon Musk's update on Twitter (TWTR))
- TSLA +6.7% (shares higher following Elon Musk's update on Twitter (TWTR))
- CHPT +5.4% (stock offering)
- BBIO +5.4% (entered into a definitive agreement with an undisclosed purchaser to sell its PRV for $110 mln)
- AVTR +5% (names new chairman)
- SHOP +4.3% (AFRM announces multi-year extension of exclusive partnership with SHOP in the US)
- VCYT +4.1% (highlights updated clinical guidelines from AUA and ASTRO)
- OI +4% (completes sale and leaseback transaction)
- WST +3.3% (names Bernard Birkett to combined position of CFO and COO)
- SIGA +3% (Dept of Defense awards contract for $7.5 mln of oral TPOXX)
- EDIT +2.7% (FDA grants Orphan Drug Designation to EDIT-301)
- PAG +2.7% (increases dividend increases share repurchase authorization to $250 mln)
- OXY +2.1% (10% owner Berkshire Hathaway (Warren Buffett) disclosed the purchase of ~902K shares worth ~$51.7 mln (transaction dates 5/10-5/11))
- GM +2% (to increase wages at Mexico plant according to Bloomberg)
- GE +1% (co expects improvement in 2H22 according to Reuters)
Analyst comments:
- FSLR +5.1% (upgraded to Overweight from Neutral at Piper Sandler)
- CPA +2.1% (upgraded to Overweight from Underweight at Barclays)
- DNUT +1.8% (upgraded to Buy from Hold at HSBC Securities)